• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

植入式心脏复律除颤器导线参数在左心室辅助装置植入后的变化。

Alterations in implantable cardioverter defibrillator lead parameters following left ventricular assist device implantation.

作者信息

Gittess David, King David J, Brady Steven, Li Ang, Guo Yi, Geiger Sara, Ahmed Mustafa M, Parker Alex M, Goel Ramil

机构信息

Division of Internal Medicine, University of Florida, Gainesville, FL.

Health Outcomes & Biomedical Informatics, University of Florida, Gainesville, FL.

出版信息

JHLT Open. 2025 Jul 21;10:100350. doi: 10.1016/j.jhlto.2025.100350. eCollection 2025 Nov.

DOI:10.1016/j.jhlto.2025.100350
PMID:40837543
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12362136/
Abstract

BACKGROUND

Left ventricular assist devices (LVADs) are increasingly used in the management of advanced heart failure. The majority of these patients have pre-existing implantable cardioverter defibrillators (ICDs). The proximity between the LVAD inflow cannula and right ventricular (RV) defibrillation lead raises the potential for disruption of ICD function.

METHODS

This is a retrospective analysis of 95 patients with ICDs at a single tertiary care center who underwent LVAD implantation and who met inclusion criteria. The primary outcome was changes in the pre-operative and post-operative transvenous ICD RV lead parameters. These changes were stratified by the age of the RV lead and analyzed via a paired t-test. The secondary outcome was disruption to the ICD requiring an intervention.

RESULTS

LVAD implantation was associated with significant decreases in sensed amplitude (p < 0.01) and high voltage impedance (p < 0.01) and an increase in capture threshold (p = 0.017). When stratified by age of the RV lead, patients with leads older than two years had similar trends in all parameters. However, RV leads that were two years old or younger only showed a significant change in high voltage impedance (p < 0.01). Mechanical disruption of the ICD related to the surgery was infrequent but significant.

CONCLUSION

Because LVAD implantation is capable of impacting ICD function and causing mechanical disruption, close monitoring should be paid to the ICD in the peri-operative period including obtaining a full interrogation.

摘要

背景

左心室辅助装置(LVAD)在晚期心力衰竭的治疗中应用越来越广泛。这些患者中的大多数已植入心脏复律除颤器(ICD)。LVAD流入插管与右心室(RV)除颤导线之间的接近度增加了ICD功能中断的可能性。

方法

这是一项对单一三级医疗中心95例植入ICD且接受LVAD植入并符合纳入标准的患者进行的回顾性分析。主要结局是术前和术后经静脉ICD右心室导线参数的变化。这些变化按右心室导线的使用年限分层,并通过配对t检验进行分析。次要结局是ICD需要干预的功能中断情况。

结果

LVAD植入与感知振幅显著降低(p < 0.01)、高压阻抗显著降低(p < 0.01)以及捕获阈值升高(p = 0.017)相关。按右心室导线的使用年限分层时,使用年限超过两年的导线在所有参数上有类似趋势。然而,使用年限为两年或更短的右心室导线仅在高压阻抗方面有显著变化(p < 0.01)。与手术相关的ICD机械性中断很少见但很显著。

结论

由于LVAD植入能够影响ICD功能并导致机械性中断,因此在围手术期应对ICD进行密切监测,包括进行全面问询。

相似文献

1
Alterations in implantable cardioverter defibrillator lead parameters following left ventricular assist device implantation.植入式心脏复律除颤器导线参数在左心室辅助装置植入后的变化。
JHLT Open. 2025 Jul 21;10:100350. doi: 10.1016/j.jhlto.2025.100350. eCollection 2025 Nov.
2
A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context.对不同患者群体中植入式心脏复律除颤器治疗的效果和成本相关证据的综述,以及在英国背景下对这些群体的成本效益和成本效用进行建模。
Health Technol Assess. 2006 Aug;10(27):iii-iv, ix-xi, 1-164. doi: 10.3310/hta10270.
3
Implantable Cardioverter-Defibrillator Use in Patients With Left Ventricular Assist Devices: A Systematic Review and Meta-Analysis.植入式心脏转复除颤器在左心室辅助装置患者中的应用:系统评价和荟萃分析。
JACC Heart Fail. 2016 Oct;4(10):772-779. doi: 10.1016/j.jchf.2016.05.003. Epub 2016 Jul 6.
4
The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation.终末期心力衰竭患者使用左心室辅助装置的临床疗效及成本效益:一项系统评价与经济学评估
Health Technol Assess. 2005 Nov;9(45):1-132, iii-iv. doi: 10.3310/hta9450.
5
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
6
The Impact of Preoperative Right Ventricular Dysfunction and Ventricular Arrhythmias on Left Ventricular Assist Device Outcomes.术前右心室功能障碍和室性心律失常对左心室辅助装置治疗效果的影响。
ASAIO J. 2025 Sep 1;71(9):736-743. doi: 10.1097/MAT.0000000000002402. Epub 2025 Feb 20.
7
Device-Related Complications in Transvenous Versus Subcutaneous Defibrillator Therapy During Long-Term Follow-Up: The PRAETORIAN-XL Trial.长期随访期间经静脉与皮下植入式心律转复除颤器治疗的器械相关并发症:PRAETORIAN-XL试验
Circulation. 2025 Jul 22;152(3):172-182. doi: 10.1161/CIRCULATIONAHA.125.074576. Epub 2025 Apr 25.
8
Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure: systematic review and economic evaluation.用于治疗心律失常的植入式心脏复律除颤器和用于治疗心力衰竭的心脏再同步治疗:系统评价与经济学评估
Health Technol Assess. 2014 Aug;18(56):1-560. doi: 10.3310/hta18560.
9
Implantable Cardioverter-Defibrillator Therapy in Brugada Syndrome: A 30-Year Single-Center Experience.植入式心脏复律除颤器治疗Brugada综合征:30年单中心经验
JACC Clin Electrophysiol. 2025 Jun;11(6):1174-1188. doi: 10.1016/j.jacep.2025.01.013. Epub 2025 Mar 12.
10
Original research: deactivation of ICDs at the end of life: a systematic review of clinical practices and provider and patient attitudes.原始研究:生命末期 ICD 的去激活:临床实践以及提供者和患者态度的系统评价。
Am J Nurs. 2011 Oct;111(10):26-35. doi: 10.1097/01.NAJ.0000406411.49438.91.

本文引用的文献

1
Cardiac Reverse Remodeling Mediated by HeartMate 3 Left Ventricular Assist Device: Comparison to Older Generation Devices.HeartMate 3左心室辅助装置介导的心脏逆向重构:与前代装置的比较。
ASAIO J. 2024 Dec 1;70(12):1060-1066. doi: 10.1097/MAT.0000000000002245. Epub 2024 May 28.
2
Importance of electromagnetic interactions between ICD and VAD devices-Mechanistic assessment.重要的是 ICD 和 VAD 设备之间的电磁相互作用-机械评估。
Artif Organs. 2022 Jun;46(6):1132-1141. doi: 10.1111/aor.14167. Epub 2022 Jan 15.
3
Reverse Remodeling With Left Ventricular Assist Devices.
左心室辅助装置的逆向重构。
Circ Res. 2021 May 14;128(10):1594-1612. doi: 10.1161/CIRCRESAHA.121.318160. Epub 2021 May 13.
4
Implantable cardiac defibrillator leads dysfunction after LVAD implantation.植入式心脏除颤器导线在 LVAD 植入后出现功能障碍。
Pacing Clin Electrophysiol. 2020 Nov;43(11):1309-1317. doi: 10.1111/pace.14004. Epub 2020 Jul 24.
5
Causes of Failure to Capture in Pacemakers and Implantable Cardioverter-defibrillators.起搏器和植入式心脏复律除颤器捕获失败的原因。
J Innov Card Rhythm Manag. 2020 Feb 15;11(2):4013-4017. doi: 10.19102/icrm.2020.110207. eCollection 2020 Feb.
6
Implantable cardioverter-defibrillator lead revision following left ventricular assist device implantation.左心室辅助装置植入后植入式心脏转复除颤器导线的修正。
J Cardiovasc Electrophysiol. 2020 Jun;31(6):1509-1518. doi: 10.1111/jce.14487. Epub 2020 Apr 29.
7
Factors Associated With High-Voltage Impedance and Subcutaneous Implantable Defibrillator Ventricular Fibrillation Conversion Success.与高电压阻抗和皮下植入式除颤器心室颤动转复成功相关的因素。
Circ Arrhythm Electrophysiol. 2019 Apr;12(4):e006665. doi: 10.1161/CIRCEP.118.006665.
8
Electromagnetic Interference from Left Ventricular Assist Device (LVAD) Inhibiting the Pacing Function of an Implantable Cardioverter-Defibrillator (ICD) Device.左心室辅助装置(LVAD)产生的电磁干扰抑制植入式心脏复律除颤器(ICD)的起搏功能。
Case Rep Cardiol. 2018 Oct 3;2018:6195045. doi: 10.1155/2018/6195045. eCollection 2018.
9
Prospective Evaluation of Implantable Cardioverter-Defibrillator Lead Function During and After Left Ventricular Assist Device Implantation.左心室辅助装置植入期间及之后植入式心脏复律除颤器导线功能的前瞻性评估
JACC Clin Electrophysiol. 2016 Jun;2(3):343-354. doi: 10.1016/j.jacep.2016.01.008. Epub 2016 Mar 23.
10
Implantable Cardioverter-Defibrillators in Patients With a Continuous-Flow Left Ventricular Assist Device: An Analysis of the INTERMACS Registry.植入式心脏转复除颤器在持续性左心室辅助装置患者中的应用:INTERMACS 注册分析。
JACC Heart Fail. 2017 Dec;5(12):916-926. doi: 10.1016/j.jchf.2017.08.014.